7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Weight Gain D015430 101 associated lipids
Glioma D005910 112 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Boumans MJ et al. Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. 2012 Ann. Rheum. Dis. pmid:22072013
Chen X et al. Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. 2012 Biol Trace Elem Res pmid:22076734
Bilgir O et al. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. 2012 Transfus. Apher. Sci. pmid:22079264
Robinson DE et al. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. 2012 Biomaterials pmid:22079008
Rojano-Mejía D et al. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. 2012 Maturitas pmid:22079369
Aliprantis AO et al. Transient muscle paralysis degrades bone via rapid osteoclastogenesis. 2012 FASEB J. pmid:22125315
Ueland T et al. TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. 2012 Curr Heart Fail Rep pmid:22453763
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Al-Sabbagh M et al. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health. 2012 J. Periodont. Res. pmid:22126530
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Talib A et al. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. 2012 Hypertens. Res. pmid:22129515
Cvija H et al. Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. 2012 Inflammation pmid:22699680
Liu L et al. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin. 2012 J Endod pmid:22703658
Nakashima T et al. New insights into osteoclastogenic signaling mechanisms. 2012 Trends Endocrinol. Metab. pmid:22705116
Kim H et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. 2012 Arch. Gynecol. Obstet. pmid:22392486
Liu S et al. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. 2012 Hum. Cell pmid:22399266
Zhao NN et al. [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. 2012 Beijing Da Xue Xue Bao pmid:22353912
Zupan J et al. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. 2012 J. Biomed. Sci. pmid:22380539
Santos VR et al. Partial- and full-mouth scaling and root planing in type 2 diabetic subjects: a 12-mo follow-up of clinical parameters and levels of cytokines and osteoclastogenesis-related factors. 2012 J. Periodont. Res. pmid:21806617
Chai YC et al. Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. 2012 Biomaterials pmid:22381474
Hudson JB et al. Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. 2012 Calcif. Tissue Int. pmid:22382900
Singh DK et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. 2012 Diabetes Res. Clin. Pract. pmid:22386825
Jia P et al. The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. 2012 Eur. J. Pharmacol. pmid:22387856
Eleftheriadis T et al. Inverse association of serum 25-hydroxyvitamin D with markers of inflammation and suppression of osteoclastic activity in hemodialysis patients. 2012 Iran J Kidney Dis pmid:22388612
Heymann MF et al. Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: comparison between carotid and femoral beds. 2012 Cytokine pmid:22402034
Sun C et al. [Acqusition of full-length gene for rabbit osteoprotegerin]. 2012 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:22404020
Quan J et al. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma. 2012 Pathology pmid:22406484
Oelzner P et al. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. 2012 Rheumatol. Int. pmid:20821212
Zhang L et al. Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. 2012 Int Endod J pmid:21899569
Hosbond SE et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. 2012 Scand. Cardiovasc. J. pmid:22506827
Fossmark R et al. Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. 2012 J. Cell. Biochem. pmid:21882222
Oka H et al. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. 2012 J. Periodontol. pmid:21910594
Korzon-Burakowska A et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. 2012 Diabet. Med. pmid:21913967
Wang JQ et al. [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. 2012 Zhongguo Gu Shang pmid:23427595
Altan BA et al. Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. 2012 Lasers Med Sci pmid:21038101
Singh PP et al. Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. 2012 Biochem. Biophys. Res. Commun. pmid:22561018
Aronis KN et al. Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults. 2012 J. Clin. Endocrinol. Metab. pmid:22563105
Zheng D et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. 2012 Bone pmid:22551876
Lee JW et al. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. 2012 J Nat Med pmid:21656335
Wang YD et al. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. 2012 Horm. Metab. Res. pmid:22556124
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Wieczorek-Baranowska A et al. Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. 2012 Metab. Clin. Exp. pmid:22000586
Ostrowska Z et al. RANKL/RANK/OPG system and bone status in females with anorexia nervosa. 2012 Bone pmid:22001124
Hou JM et al. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22902986
Ma B et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22426695
García-Martín A et al. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. 2012 Med Clin (Barc) pmid:22024564
Zijlstra WP et al. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. 2012 J. Orthop. Res. pmid:22025323
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Erkol A et al. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. 2012 Atherosclerosis pmid:22265272
Kam WW et al. The 18 kDa translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice. 2012 PLoS ONE pmid:22295097
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Reginster JY et al. Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. 2012 Bone pmid:22270053
Garlet GP et al. Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. 2012 J Endod pmid:22244633
Rimondi E et al. Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells. 2012 Invest New Drugs pmid:21541705
Makras P et al. Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis. 2012 J. Clin. Endocrinol. Metab. pmid:22278426
Stępień E et al. Osteoprotegerin, but not osteopontin, as a potential predictor of vascular calcification in normotensive subjects. 2012 Hypertens. Res. pmid:22278625
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Deuell KA et al. RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. 2012 J. Vasc. Res. pmid:22948607
Li F et al. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. 2012 Fitoterapia pmid:22951288
Buckle CH et al. Soluble rank ligand produced by myeloma cells causes generalised bone loss in multiple myeloma. 2012 PLoS ONE pmid:22952578
Shen P et al. Expression of osteoprotegerin in placenta and its association with preeclampsia. 2012 PLoS ONE pmid:22952959
Diercke K et al. IL-1β and compressive forces lead to a significant induction of RANKL-expression in primary human cementoblasts. 2012 J Orofac Orthop pmid:22955577
Guo D et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. 2012 Mol. Cell. Biochem. pmid:22167620
Svensson M et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. 2012 Nephrol. Dial. Transplant. pmid:22172725
Kraus D et al. Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. 2012 Clin Oral Investig pmid:22186940
Zhao N et al. Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22196183
Chen J et al. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. 2012 Rheumatol. Int. pmid:22210270
Giannopoulou C et al. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. 2012 Acta Odontol. Scand. pmid:22214279
Bloch SL and Sørensen MS Otosclerosis: a perilabyrinthine threshold phenomenon. 2012 Acta Otolaryngol. pmid:22217131
Wang S and Liu YS [Advance on arterial calcification]. 2012 Sheng Li Ke Xue Jin Zhan pmid:23189619
Rashtchizadeh N et al. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients. 2012 Ther Apher Dial pmid:23190522
Pecchi E et al. A potential role of chondroitin sulfate on bone in osteoarthritis: inhibition of prostaglandin E₂ and matrix metalloproteinases synthesis in interleukin-1β-stimulated osteoblasts. 2012 Osteoarthr. Cartil. pmid:22179028
Xue Y et al. Adipokines in psoriatic arthritis patients: the correlations with osteoclast precursors and bone erosions. 2012 PLoS ONE pmid:23144698
Adamczyk T et al. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. 2012 Pol. Arch. Med. Wewn. pmid:22237719
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Kim IS et al. Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. 2012 J. Dent. Res. pmid:23086742
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Davenport C et al. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. 2012 Eur. J. Clin. Invest. pmid:22803952
Brandenburg V et al. Calcification inhibitors in vascular calciphylaxis associated with normal renal function. 2012 Thromb. Haemost. pmid:23092963
Histing T et al. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. 2012 J. Surg. Res. pmid:20888595
Mirzaei K et al. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. 2012 Minerva Med. pmid:22805623
Ryser MD et al. Osteoprotegerin in bone metastases: mathematical solution to the puzzle. 2012 PLoS Comput. Biol. pmid:23093918
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Giaginis C et al. Correlation of plasma osteoprotegerin (OPG) and receptor activator of the nuclear factor κB ligand (RANKL) levels with clinical risk factors in patients with advanced carotid atherosclerosis. 2012 Med. Sci. Monit. pmid:23018352
Wang C et al. Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. 2012 J. Bone Miner. Res. pmid:22807154
Martínez E et al. Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir. 2012 AIDS pmid:23018438
Poerschke RL et al. Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. 2012 J. Biochem. Mol. Toxicol. pmid:22807314
Chandran V Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. 2012 J Rheumatol Suppl pmid:22751596
Melchiorre D et al. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology. 2012 J. Rheumatol. pmid:22753650
Tenta R et al. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. 2012 J. Endocrinol. Invest. pmid:21606670
Zhou W and Mei L Effect of autologous bone marrow stromal cells transduced with osteoprotegerin on periodontal bone regeneration in canine periodontal window defects. 2012 Int J Periodontics Restorative Dent pmid:22754911
Baud'huin M et al. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22761317
Histing T et al. Increased osteoblast and osteoclast activity in female senescence-accelerated, osteoporotic SAMP6 mice during fracture healing. 2012 J. Surg. Res. pmid:21571305

Table of Content